Next-Generation Biologics Market Report

Global Next-Generation Biologics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：178
  • REPORT CODE：GMM869876
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Next-Generation Biologics market report explains the definition, types, applications, major countries, and major players of the Next-Generation Biologics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Allergan

    • Biogen Idec

    • Molecular Partners

    • Bayer

    • Novo Nordisk

    • Eli Lilly

    • Sanofi

    • Roche

    • Kyowa Hakko Kirin

    • Pfizer

    By Type:

    • Antibodies

    • Regenerative medicine

    • Insulins

    • Growth hormones

    • Other

    By End-User:

    • Medical

    • Scientific Research

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Next-Generation Biologics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Next-Generation Biologics Outlook to 2028- Original Forecasts

    • 2.2 Next-Generation Biologics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Next-Generation Biologics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Next-Generation Biologics Market- Recent Developments

    • 6.1 Next-Generation Biologics Market News and Developments

    • 6.2 Next-Generation Biologics Market Deals Landscape

    7 Next-Generation Biologics Raw Materials and Cost Structure Analysis

    • 7.1 Next-Generation Biologics Key Raw Materials

    • 7.2 Next-Generation Biologics Price Trend of Key Raw Materials

    • 7.3 Next-Generation Biologics Key Suppliers of Raw Materials

    • 7.4 Next-Generation Biologics Market Concentration Rate of Raw Materials

    • 7.5 Next-Generation Biologics Cost Structure Analysis

      • 7.5.1 Next-Generation Biologics Raw Materials Analysis

      • 7.5.2 Next-Generation Biologics Labor Cost Analysis

      • 7.5.3 Next-Generation Biologics Manufacturing Expenses Analysis

    8 Global Next-Generation Biologics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Next-Generation Biologics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Next-Generation Biologics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Next-Generation Biologics Market Outlook by Types and Applications to 2022

    • 9.1 Global Next-Generation Biologics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Regenerative medicine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Insulins Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Growth hormones Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Next-Generation Biologics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Medical Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Scientific Research Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Next-Generation Biologics Market Analysis and Outlook till 2022

    • 10.1 Global Next-Generation Biologics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Next-Generation Biologics Consumption (2017-2022)

      • 10.2.2 Canada Next-Generation Biologics Consumption (2017-2022)

      • 10.2.3 Mexico Next-Generation Biologics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Next-Generation Biologics Consumption (2017-2022)

      • 10.3.2 UK Next-Generation Biologics Consumption (2017-2022)

      • 10.3.3 Spain Next-Generation Biologics Consumption (2017-2022)

      • 10.3.4 Belgium Next-Generation Biologics Consumption (2017-2022)

      • 10.3.5 France Next-Generation Biologics Consumption (2017-2022)

      • 10.3.6 Italy Next-Generation Biologics Consumption (2017-2022)

      • 10.3.7 Denmark Next-Generation Biologics Consumption (2017-2022)

      • 10.3.8 Finland Next-Generation Biologics Consumption (2017-2022)

      • 10.3.9 Norway Next-Generation Biologics Consumption (2017-2022)

      • 10.3.10 Sweden Next-Generation Biologics Consumption (2017-2022)

      • 10.3.11 Poland Next-Generation Biologics Consumption (2017-2022)

      • 10.3.12 Russia Next-Generation Biologics Consumption (2017-2022)

      • 10.3.13 Turkey Next-Generation Biologics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Next-Generation Biologics Consumption (2017-2022)

      • 10.4.2 Japan Next-Generation Biologics Consumption (2017-2022)

      • 10.4.3 India Next-Generation Biologics Consumption (2017-2022)

      • 10.4.4 South Korea Next-Generation Biologics Consumption (2017-2022)

      • 10.4.5 Pakistan Next-Generation Biologics Consumption (2017-2022)

      • 10.4.6 Bangladesh Next-Generation Biologics Consumption (2017-2022)

      • 10.4.7 Indonesia Next-Generation Biologics Consumption (2017-2022)

      • 10.4.8 Thailand Next-Generation Biologics Consumption (2017-2022)

      • 10.4.9 Singapore Next-Generation Biologics Consumption (2017-2022)

      • 10.4.10 Malaysia Next-Generation Biologics Consumption (2017-2022)

      • 10.4.11 Philippines Next-Generation Biologics Consumption (2017-2022)

      • 10.4.12 Vietnam Next-Generation Biologics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Next-Generation Biologics Consumption (2017-2022)

      • 10.5.2 Colombia Next-Generation Biologics Consumption (2017-2022)

      • 10.5.3 Chile Next-Generation Biologics Consumption (2017-2022)

      • 10.5.4 Argentina Next-Generation Biologics Consumption (2017-2022)

      • 10.5.5 Venezuela Next-Generation Biologics Consumption (2017-2022)

      • 10.5.6 Peru Next-Generation Biologics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Next-Generation Biologics Consumption (2017-2022)

      • 10.5.8 Ecuador Next-Generation Biologics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Next-Generation Biologics Consumption (2017-2022)

      • 10.6.2 Kuwait Next-Generation Biologics Consumption (2017-2022)

      • 10.6.3 Oman Next-Generation Biologics Consumption (2017-2022)

      • 10.6.4 Qatar Next-Generation Biologics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Next-Generation Biologics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Next-Generation Biologics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Next-Generation Biologics Consumption (2017-2022)

      • 10.7.2 South Africa Next-Generation Biologics Consumption (2017-2022)

      • 10.7.3 Egypt Next-Generation Biologics Consumption (2017-2022)

      • 10.7.4 Algeria Next-Generation Biologics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Next-Generation Biologics Consumption (2017-2022)

      • 10.8.2 New Zealand Next-Generation Biologics Consumption (2017-2022)

    11 Global Next-Generation Biologics Competitive Analysis

    • 11.1 Allergan

      • 11.1.1 Allergan Company Details

      • 11.1.2 Allergan Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Allergan Next-Generation Biologics Main Business and Markets Served

      • 11.1.4 Allergan Next-Generation Biologics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Biogen Idec

      • 11.2.1 Biogen Idec Company Details

      • 11.2.2 Biogen Idec Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Biogen Idec Next-Generation Biologics Main Business and Markets Served

      • 11.2.4 Biogen Idec Next-Generation Biologics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Molecular Partners

      • 11.3.1 Molecular Partners Company Details

      • 11.3.2 Molecular Partners Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Molecular Partners Next-Generation Biologics Main Business and Markets Served

      • 11.3.4 Molecular Partners Next-Generation Biologics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Bayer

      • 11.4.1 Bayer Company Details

      • 11.4.2 Bayer Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Bayer Next-Generation Biologics Main Business and Markets Served

      • 11.4.4 Bayer Next-Generation Biologics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novo Nordisk

      • 11.5.1 Novo Nordisk Company Details

      • 11.5.2 Novo Nordisk Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novo Nordisk Next-Generation Biologics Main Business and Markets Served

      • 11.5.4 Novo Nordisk Next-Generation Biologics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Eli Lilly

      • 11.6.1 Eli Lilly Company Details

      • 11.6.2 Eli Lilly Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Eli Lilly Next-Generation Biologics Main Business and Markets Served

      • 11.6.4 Eli Lilly Next-Generation Biologics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sanofi

      • 11.7.1 Sanofi Company Details

      • 11.7.2 Sanofi Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sanofi Next-Generation Biologics Main Business and Markets Served

      • 11.7.4 Sanofi Next-Generation Biologics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Roche

      • 11.8.1 Roche Company Details

      • 11.8.2 Roche Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Roche Next-Generation Biologics Main Business and Markets Served

      • 11.8.4 Roche Next-Generation Biologics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Kyowa Hakko Kirin

      • 11.9.1 Kyowa Hakko Kirin Company Details

      • 11.9.2 Kyowa Hakko Kirin Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Kyowa Hakko Kirin Next-Generation Biologics Main Business and Markets Served

      • 11.9.4 Kyowa Hakko Kirin Next-Generation Biologics Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Pfizer

      • 11.10.1 Pfizer Company Details

      • 11.10.2 Pfizer Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Pfizer Next-Generation Biologics Main Business and Markets Served

      • 11.10.4 Pfizer Next-Generation Biologics Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Next-Generation Biologics Market Outlook by Types and Applications to 2028

    • 12.1 Global Next-Generation Biologics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Regenerative medicine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Insulins Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Growth hormones Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Next-Generation Biologics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Medical Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Next-Generation Biologics Market Analysis and Outlook to 2028

    • 13.1 Global Next-Generation Biologics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Next-Generation Biologics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.2 UK Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.5 France Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Next-Generation Biologics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.3 India Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Next-Generation Biologics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Next-Generation Biologics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Next-Generation Biologics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Next-Generation Biologics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Next-Generation Biologics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Next-Generation Biologics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Next-Generation Biologics

    • Figure of Next-Generation Biologics Picture

    • Table Global Next-Generation Biologics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Next-Generation Biologics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Regenerative medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Insulins Consumption and Growth Rate (2017-2022)

    • Figure Global Growth hormones Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Consumption and Growth Rate (2017-2022)

    • Figure Global Scientific Research Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Next-Generation Biologics Consumption by Country (2017-2022)

    • Table North America Next-Generation Biologics Consumption by Country (2017-2022)

    • Figure United States Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Canada Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Table Europe Next-Generation Biologics Consumption by Country (2017-2022)

    • Figure Germany Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure UK Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Spain Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure France Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Italy Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Finland Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Norway Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Poland Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Russia Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Table APAC Next-Generation Biologics Consumption by Country (2017-2022)

    • Figure China Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Japan Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure India Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Table South America Next-Generation Biologics Consumption by Country (2017-2022)

    • Figure Brazil Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Chile Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Peru Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Table GCC Next-Generation Biologics Consumption by Country (2017-2022)

    • Figure Bahrain Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Oman Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Table Africa Next-Generation Biologics Consumption by Country (2017-2022)

    • Figure Nigeria Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Table Oceania Next-Generation Biologics Consumption by Country (2017-2022)

    • Figure Australia Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Next-Generation Biologics Consumption and Growth Rate (2017-2022)

    • Table Allergan Company Details

    • Table Allergan Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Next-Generation Biologics Main Business and Markets Served

    • Table Allergan Next-Generation Biologics Product Portfolio

    • Table Biogen Idec Company Details

    • Table Biogen Idec Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Idec Next-Generation Biologics Main Business and Markets Served

    • Table Biogen Idec Next-Generation Biologics Product Portfolio

    • Table Molecular Partners Company Details

    • Table Molecular Partners Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Molecular Partners Next-Generation Biologics Main Business and Markets Served

    • Table Molecular Partners Next-Generation Biologics Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Next-Generation Biologics Main Business and Markets Served

    • Table Bayer Next-Generation Biologics Product Portfolio

    • Table Novo Nordisk Company Details

    • Table Novo Nordisk Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Next-Generation Biologics Main Business and Markets Served

    • Table Novo Nordisk Next-Generation Biologics Product Portfolio

    • Table Eli Lilly Company Details

    • Table Eli Lilly Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Next-Generation Biologics Main Business and Markets Served

    • Table Eli Lilly Next-Generation Biologics Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Next-Generation Biologics Main Business and Markets Served

    • Table Sanofi Next-Generation Biologics Product Portfolio

    • Table Roche Company Details

    • Table Roche Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Next-Generation Biologics Main Business and Markets Served

    • Table Roche Next-Generation Biologics Product Portfolio

    • Table Kyowa Hakko Kirin Company Details

    • Table Kyowa Hakko Kirin Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Hakko Kirin Next-Generation Biologics Main Business and Markets Served

    • Table Kyowa Hakko Kirin Next-Generation Biologics Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Next-Generation Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Next-Generation Biologics Main Business and Markets Served

    • Table Pfizer Next-Generation Biologics Product Portfolio

    • Figure Global Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Regenerative medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth hormones Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Next-Generation Biologics Consumption Forecast by Country (2022-2028)

    • Table North America Next-Generation Biologics Consumption Forecast by Country (2022-2028)

    • Figure United States Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Next-Generation Biologics Consumption Forecast by Country (2022-2028)

    • Figure Germany Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Next-Generation Biologics Consumption Forecast by Country (2022-2028)

    • Figure China Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Next-Generation Biologics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Next-Generation Biologics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Next-Generation Biologics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Next-Generation Biologics Consumption Forecast by Country (2022-2028)

    • Figure Australia Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Next-Generation Biologics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US